Guido Baselli
Overview
Explore the profile of Guido Baselli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
1867
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hassan S, Baselli G, Mollica L, Rossi R, Chand H, El-Beshlawy A, et al.
Blood Adv
. 2024 Apr;
8(11):2880-2889.
PMID: 38593222
Inhibitor development is the most severe complication of hemophilia A (HA) care and is associated with increased morbidity and mortality. This study aimed to use a novel immunoglobulin G epitope...
2.
Caon E, Martins M, Hodgetts H, Blanken L, Vilia M, Levi A, et al.
J Hepatol
. 2024 Feb;
80(6):941-956.
PMID: 38365182
Background & Aims: The PNPLA3 rs738409 C>G (encoding for I148M) variant is a risk locus for the fibrogenic progression of chronic liver diseases, a process driven by hepatic stellate cells...
3.
Cherubini A, Ostadreza M, Jamialahmadi O, Pelusi S, Rrapaj E, Casirati E, et al.
Nat Med
. 2024 Jan;
30(4):1212.
PMID: 38267549
No abstract available.
4.
Cherubini A, Ostadreza M, Jamialahmadi O, Pelusi S, Rrapaj E, Casirati E, et al.
Nat Med
. 2023 Sep;
29(10):2643-2655.
PMID: 37749332
Fatty liver disease (FLD) caused by metabolic dysfunction is the leading cause of liver disease and the prevalence is rising, especially in women. Although during reproductive age women are protected...
5.
Farini A, Tripodi L, Villa C, Strati F, Facoetti A, Baselli G, et al.
EMBO Mol Med
. 2022 Dec;
15(3):e16244.
PMID: 36533294
Duchenne muscular dystrophy (DMD) is a progressive severe muscle-wasting disease caused by mutations in DMD, encoding dystrophin, that leads to loss of muscle function with cardiac/respiratory failure and premature death....
6.
Baselli G, Romeo S, Valenti L
J Hepatol
. 2022 Aug;
77(5):1459-1461.
PMID: 35985546
No abstract available.
7.
Degenhardt F, Ellinghaus D, Juzenas S, Lerga-Jaso J, Wendorff M, Maya-Miles D, et al.
Hum Mol Genet
. 2022 Jul;
31(23):3945-3966.
PMID: 35848942
Given the highly variable clinical phenotype of Coronavirus disease 2019 (COVID-19), a deeper analysis of the host genetic contribution to severe COVID-19 is important to improve our understanding of underlying...
8.
Mancina R, Sasidharan K, Lindblom A, Wei Y, Ciociola E, Jamialahmadi O, et al.
Nat Metab
. 2022 Feb;
4(1):60-75.
PMID: 35102341
Fatty liver disease (FLD) is a growing health issue with burdening unmet clinical needs. FLD has a genetic component but, despite the common variants already identified, there is still a...
9.
Scagliola A, Miluzio A, Ventura G, Oliveto S, Cordiglieri C, Manfrini N, et al.
Nat Commun
. 2021 Aug;
12(1):4878.
PMID: 34385447
A postprandial increase of translation mediated by eukaryotic Initiation Factor 6 (eIF6) occurs in the liver. Its contribution to steatosis and disease is unknown. In this study we address whether...
10.
Grimaudo S, Dongiovanni P, Pihlajamaki J, Eslam M, Yki-Jarvinen H, Pipitone R, et al.
Liver Int
. 2021 Jul;
41(11):2712-2719.
PMID: 34268860
Background And Aims: Farnesoid X receptor (FXR) plays a key role in bile acid and lipid homeostasis. Experimental evidence suggests that it can modulate liver damage related to nonalcoholic fatty...